(Q41652782)

English

Multicentre double-blind randomized controlled trial of perhexiline as a metabolic modulator to augment myocardial protection in patients with left ventricular hypertrophy undergoing cardiac surgery

scientific article published on 23 December 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

6 October 2017

Multicentre double-blind randomized controlled trial of perhexiline as a metabolic modulator to augment myocardial protection in patients with left ventricular hypertrophy undergoing cardiac surgery (English)

1 reference

Europe PubMed Central

6 October 2017

multicenter clinical trial

0 references

left ventricular hypertrophy

1 reference

based on heuristic

inferred from title

author name string

Eshan L Senanayake

1

1 reference

Europe PubMed Central

6 October 2017

Neil J Howell

2

1 reference

Europe PubMed Central

6 October 2017

Aaron M Ranasinghe

3

1 reference

Europe PubMed Central

6 October 2017

Nigel E Drury

4

1 reference

Europe PubMed Central

6 October 2017

Nick Freemantle

5

1 reference

Europe PubMed Central

6 October 2017

Michael Frenneaux

6

1 reference

Europe PubMed Central

6 October 2017

Tessa Oelofse

7

1 reference

Europe PubMed Central

6 October 2017

David Green

8

1 reference

Europe PubMed Central

6 October 2017

Ian C Wilson

9

1 reference

Europe PubMed Central

6 October 2017

Stephen J Rooney

10

1 reference

Europe PubMed Central

6 October 2017

Jorge Mascaro

11

1 reference

Europe PubMed Central

6 October 2017

Timothy R Graham

12

1 reference

Europe PubMed Central

6 October 2017

Sunil Bhudia

13

1 reference

Europe PubMed Central

6 October 2017

Michael Lewis

14

1 reference

Europe PubMed Central

6 October 2017

Domenico Pagano

15

1 reference

Europe PubMed Central

6 October 2017

publication date

23 December 2014

1 reference

Europe PubMed Central

6 October 2017

European Journal of Cardio-Thoracic Surgery

1 reference

Europe PubMed Central

6 October 2017

48

1 reference

Europe PubMed Central

6 October 2017

3

1 reference

Europe PubMed Central

6 October 2017

354-362

1 reference

Europe PubMed Central

6 October 2017

Left ventricular hypertrophy: pathogenesis, detection, and prognosis

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZU452

21 January 2018

Natural history of aortic valve stenosis of varying severity in the elderly.

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZU452

21 January 2018

2008 Focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Commit

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZU452

21 January 2018

The failing heart--an engine out of fuel

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZU452

21 January 2018

Glucose-insulin-potassium reduces the incidence of low cardiac output episodes after aortic valve replacement for aortic stenosis in patients with left ventricular hypertrophy: results from the Hypertrophy, Insulin, Glucose, and Electrolytes (HINGE)

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZU452

21 January 2018

Improved myocardial protection during coronary artery surgery with glucose-insulin-potassium: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZU452

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZU452

21 January 2018

Metabolic modulation with perhexiline in chronic heart failure: a randomized, controlled trial of short-term use of a novel treatment

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZU452

21 January 2018

Metabolic modulator perhexiline corrects energy deficiency and improves exercise capacity in symptomatic hypertrophic cardiomyopathy.

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZU452

21 January 2018

The effect of perhexiline on myocardial protection during coronary artery surgery: a two-centre, randomized, double-blind, placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZU452

21 January 2018

Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZU452

21 January 2018

Interpreting the results of secondary end points and subgroup analyses in clinical trials: should we lock the crazy aunt in the attic?

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZU452

21 January 2018

Relationship between plasma, atrial and ventricular perhexiline concentrations in humans: insights into factors affecting myocardial uptake

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZU452

21 January 2018

Effects of perhexiline-induced fuel switch on the cardiac proteome and metabolome

1 reference

https://api.crossref.org/works/10.1093%2FEJCTS%2FEZU452

21 January 2018

Identifiers

10.1093/EJCTS/EZU452

1 reference

Europe PubMed Central

6 October 2017

1 reference

Europe PubMed Central

6 October 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41652782&oldid=1925522088"